ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $2,172,000 | -84.5% | 300,000 | -87.8% | 0.00% | -100.0% |
| Q4 2016 | $14,014,000 | -41.8% | 2,450,000 | +30.2% | 0.00% | -33.3% |
| Q3 2016 | $24,085,000 | +51.0% | 1,881,647 | +47.0% | 0.00% | +50.0% |
| Q2 2016 | $15,949,000 | +49.0% | 1,279,999 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $10,701,000 | +20.1% | 1,279,999 | +42.2% | 0.00% | 0.0% |
| Q4 2015 | $8,910,000 | +3.8% | 900,000 | +28.6% | 0.00% | 0.0% |
| Q3 2015 | $8,582,000 | -69.0% | 700,000 | -61.2% | 0.00% | -75.0% |
| Q2 2015 | $27,664,000 | -66.4% | 1,803,358 | -62.6% | 0.00% | -60.0% |
| Q1 2015 | $82,372,000 | +98.4% | 4,825,520 | +77.7% | 0.01% | +100.0% |
| Q4 2014 | $41,511,000 | +327.4% | 2,714,933 | +196.3% | 0.01% | +400.0% |
| Q3 2014 | $9,713,000 | -30.5% | 916,333 | -0.3% | 0.00% | -50.0% |
| Q2 2014 | $13,985,000 | +185.9% | 919,433 | +141.9% | 0.00% | +100.0% |
| Q1 2014 | $4,892,000 | +439.4% | 380,109 | +576.4% | 0.00% | – |
| Q3 2013 | $907,000 | -71.7% | 56,200 | -76.7% | 0.00% | -100.0% |
| Q2 2013 | $3,203,000 | – | 241,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|